Bausch Health
BHC
#4785
Rank
โ‚น176.59 B
Marketcap
โ‚น475.68
Share price
-1.95%
Change (1 day)
-14.18%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

P/S ratio for Bausch Health (BHC)

P/S ratio at the end of 2025: 0.2605

According to Bausch Health 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.93. At the end of 2025 the company had a P/S ratio of 0.2605.

P/S ratio history for Bausch Health from 2001 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20250.2605-10.88%
20240.2923-12.92%
20230.335719.54%
20220.2808-75.95%
20211.1727.41%
20200.9164-24.87%
20191.2257.59%
20180.7740-7.09%
20170.833060.51%
20160.5190-84.39%
20153.32-43.06%
20145.84-13.57%
20136.7629.73%
20125.21-12.06%
20115.92-18.21%
20107.24167.62%
20092.7137%
20081.97-23.21%
20072.57-19.12%
20063.18-21.21%
20054.0434.67%
20043.00-27.66%
20034.14-21.82%
20025.30-65.11%
200115.2

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
OPKO Health
OPK
1.35 629.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
92.5 49,824.76%๐Ÿ‡บ๐Ÿ‡ธ USA